comparemela.com

Latest Breaking News On - Santen pharmaceutical co ltd - Page 3 : comparemela.com

Santen Pharmaceutical Co , Ltd (OTCMKTS:SNPHY) Short Interest Down 99 5% in March

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 100 shares, a decrease of 99.5% from the February 29th total of 20,800 shares. Based on an average daily trading volume, of […]

Santen pharmaceutical co ltdSanten pharmaceutical company profileGet free reportSanten pharmaceutical dailySanten pharmaceutical

Santen Pharmaceutical : obtains manufacturing and marketing approval in Japan for Alesion® eyelid cream (epinastine hydrochloride), a new treatment for allergic conjunctivitis -March 26, 2024 at 02:10 am EDT

Santen obtains manufacturing and marketing approval in Japan for Alesion®eyelid cream , a new treatment for allergic conjunctivitis rn .

Peter sallstigSanten pharmaceutical co ltdBoehringer ingelheimCorporate communicationsJournal of the japanese ophthalmological societyJapanese ocular allergy societyJapanese society of ophthalmic allergy researchAllergen challengeChief medical officerJapanese societyOphthalmic allergy researchClinical managementAllergic conjunctival diseaseJapanese ophthalmological society

Santen Pharmaceutical : Announces Completion of Share Buyback -March 25, 2024 at 03:07 am EDT

March 25, 2024 Santen Announces Completion of Share Buyback Santen Pharmaceutical Co., Ltd. announced completion of the share buyback as.

Takeshi itoGuillaume sakumaHead officeSanten pharmaceutical co ltdCompanies act japanAir groupAnnounces completionCompanies act

Santen Pharmaceutical : Announces Change of Representative Director of the Board -March 25, 2024 at 03:07 am EDT

March 25, 2024 Santen Announces Change of Representative Director of the Board Santen Pharmaceutical Co., Ltd. announced the change of.

Akira kurokawaGuillaume sakumaTakeshi itoHead officeAir groupSanten pharmaceutical co ltdAnnounces changeRepresentative directorChief executive officer

Santen Pharmaceutical : Announces Cancellation of Treasury Shares -March 25, 2024 at 03:07 am EDT

March 25, 2024 Santen Announces Cancellation of Treasury Shares Santen Pharmaceutical Co., Ltd. announced that it has resolved at the Board.

Takeshi itoGuillaume sakumaHead officeAir groupCompanies act japanSanten pharmaceutical co ltdAnnounces cancellationCompanies act

vimarsana © 2020. All Rights Reserved.